Skip to content

The Effects of Receiving Warm Footbath With Lavender Essential Oil on Sleep and Comfort

The Effects of Receiving Warm Footbath With Lavender Essential Oil on Sleep and Comfort Among Ventilator-Dependent Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06380933
Enrollment
94
Registered
2024-04-24
Start date
2022-09-01
Completion date
2024-02-28
Last updated
2024-04-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Comfort, Sleep Quality

Keywords

respirator-dependent patient, warm water foot baths, lavender essential oil, sleep quality, comfort level, heartbeat, blood pressure

Brief summary

Purposes: Describe the background information and clinical characteristics of respirator-dependent patients, verify the sleep and comfort effects of respirator-dependent patients whether or not they receive a lavender essential oil warm water foot bath, and compare changes of the sleep, comfort, heartbeat, and blood pressure in respirator-dependent patients before and after receiving a lavender essential oil warm water foot bath.

Detailed description

Methods: This study is a randomized clinical trial. It adopts a two-group crossover design trial and block randomly assigns groups after gender stratification. The experimental group first received a foot bath with lavender essential oil at 41-42C warm water for 20 minutes for 3 days, then rested for 3 days, and then received routine care for 3 days; the control group first received routine care for 3 days, then rested for 3 days, and then received lavender essential oil 41-42C warm water foot bath for 20 minutes for 3 days. The measurement tools used self-made structured questionnaires, the Richards-Campbell Sleep Questionnaire (RCSQ), Numerical Rating of Comfort (NRC), and heartbeat and blood pressure monitors. Data analysis included descriptive statistics, Chi-square and Fisher's exact correction tests, unpaired t tests and repeated measures ANOVA inferential statistical analysis.

Interventions

OTHERexperimental group

first received a foot bath with lavender essential oil at 41-42C warm water for 20 minutes for 3 days, then rested for 3 days, and then received routine care for 3 days

Sponsors

Dalin Tzu Chi General Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Intervention model description

two-group crossover design trial and block randomly assigns groups after gender stratification. The experimental group first received a foot bath with lavender essential oil at 41-42C warm water for 20 minutes for 3 days, then rested for 3 days, and then received routine care for 3 days; the control group first received routine care for 3 days, then rested for 3 days, and then received lavender essential oil 41-42C warm water foot bath for 20 minutes for 3 days.

Eligibility

Sex/Gender
ALL
Age
45 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Patients who have been using a ventilator for 21 days or more * Individuals aged 45 years or older * Clear consciousness and the ability to compare hands or hold a pen, with proficiency in Mandarin or Taiwanese communication * Willingness to participate in the study after receiving an explanation of the research purpose

Exclusion criteria

* Individuals with severe mental illness * Those with cognitive impairments * Severe visual or hearing impairments * History of lower limb venous thrombosis * Amputation or inflammation in the lower limbs * Muscle contractures in the lower limbs * Peripheral neuropathy * Allergic history related to essential oils

Design outcomes

Primary

MeasureTime frameDescription
Richards-Campbell Sleep Questionnaireday 1 and implementation of interventions0-100mm

Secondary

MeasureTime frameDescription
Numerical Rating of Comfortday1and implementation of interventions0-10 points

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026